%0 Generic
%T Real-world clinical outcomes study of sequential novel antihormonal therapy (NAH) or radium-223 (Ra-223) treatment of metastatic castration-resistant prostate cancer (mCRPC) that progressed after first-line NAH.
%A Sartor, Oliver A.
%A George, Daniel J.
%A Tombal, Bertrand
%A Higano, Celestia S.
%A Sternberg, Cora N.
%A Miller, Kurt
%A Jiao, Xiaolong
%A Guo, Helen
%A Sandstrom, Per
%A Verholen, Frank
%A Saad, Fred
%A Shore, Neal D.
%I American Society of Clinical Oncology (ASCO)
%@ 1527-7755
%@ 0732-183X
%K Cancer Research
%K Oncology
%D 2021
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation